ClinicalTrials.gg
Status unknownNCT03482804PROCLIVEUpdated Mar 29, 2018

The Inclined Position in Case of Respiratory Discomfort in the One Year Less Infant : Study on the Profits and the Risks in the Home

An observational study in Obstruction, Airway and Sudden; Death, Infant, sponsored by Hospices Civils de Lyon. Status unknown at 2 sites in France. Open to participants aged Up to 12 Months. Per ClinicalTrials.gov, last updated 2018-03-29.

Sponsored by Hospices Civils de Lyon · Observational

The sponsor has not verified this record recently (last verified Mar 2018), so the status shown — last known as Not yet recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
90
Ages
Up to 12 Months
Sex
All
01

Study summary

The inclined position at 30 ° in case of transient respiratory discomfort is recommended since the consensus conference of September 2000. This recommendation is based on a low level of evidence (grade C). This advice is found in the health book, and in many tips for parents. However, it does not comply with the recommendations of the American Academy of Pediatrics for sleeping on the back, on a firm mattress and without other objects in the bed.

70% of pediatricians advise this position in a specific medical context according to a study of Bellaïche conducted in 2013. 40% of parents use it for no particular reason.

Anatomically, the upper airways of infants are of reduced caliber, and therefore at risk of obstruction.

A study by Bergougnioux on the cases of MIN in infants wearing a wrap-around sling shows that the flexion of the neck causes the chin to be positioned against the chest and contributes to the suffocation of the infant. This is especially important in infants under 3 months whose neck muscles do not yet support the weight of the head.

The 2009 InVS national survey of unexpected infant deaths shows that bed crashes accounted for 11.1% of all deaths reported. Among unexplained deaths, maladaptive bedding was a contributing factor, including the use of a pillow in the bed in 24.3% of cases.

It was observed in the study by Kornhauser Cerar et al in 2009 that half-sitting in a car seat for an extended duration was at the origin of a significant desaturations rate, which was also found in the car bed group. The control group "hospital bed" was not subject to these desaturations. These results support the fact that only an adapted bedding that complies with the recommendations protects against asphyxiation.

Since 2016, INPES recommends in its advice sheet on bronchiolitis for parents, a flat bed on the back.

Hypothesis :

The inclined position in infants under one year of age is at risk of unexpected death of the infant by obstruction of the upper airways, because of the changes of position that it entails, including a risk of slipping at the bottom of the bed and of asphyxiation under the covers.

02

Conditions studied

  • Obstruction, Airway
  • Sudden; Death, Infant
03

In context

Airway Obstruction

147 studies on the registry are indexed under Airway Obstruction; 25 are open to participants now.

This study's planned enrollment of 90 is below the median of 125 across 52 observational studies indexed under Airway Obstruction.

Browse Airway Obstruction studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,867 studies on the registry; 448 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 12 Months
Sexes eligible
All
Sampling method
Probability sample

Study population

Parents of infants from 0 to 12 months attending pediatric emergencies in 2 hospitals are interroged :

  • Hôpital Femme Mere Enfant (Bron)
  • Hôpital Nord-Ouest (Villefranche sur Saône) Are included infant from 0 to 12 months, lie in a proclive position while sleeping whose parents / parent authority holders informed about the terms of the study and agree to answer the questionnaire

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Infant from 0 to 12 months
  • Lie in a proclive position while sleeping
  • Whose parents / parent authority holders informed about the terms of the study and agree to answer the questionnaire

Exclusion criteria

Exclusion Criteria:

  • Refusal to participate
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
90 participants (estimated)
Patient registry
No

Interventions

  • OtherQuestionnaires

    Parents will be interviewed before being seen in consultation in the emergency room. The reason for consultation will not be taken into account, the only criterion being the age of the child. There will be no sign in the waiting room, the study will be proposed to them by the principal investigator. The questionnaires will be collected on live paper. The answers will be transferred in a second time on an Excel database protected by a password.

06

What researchers measure

Primary outcomes

  1. Sliding of the infant in the bottom of his bed in inclined position during sleep

    Sliding of the infant in the bottom of his bed in inclined position during sleep, reported by the parents during the questionnaire in the form of a closed question.

    Time frame: 1 day

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Apr 2018; primary completion for Oct 2018, 6 months later.

Of 28 observational studies under Airway Obstruction, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 28. This study's planned 6 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 23, 2018
First posted
Mar 29, 2018
StartEst.
Apr 2018
Primary completionEst.
Oct 2018
CompletionEst.
Oct 2018
Last update
Mar 29, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 29, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03482804
Responsible party
Sponsor
First posted
Mar 29, 2018
Start date
Apr 2018 (estimated)
Primary completion
Oct 2018 (estimated)
Completion
Oct 2018 (estimated)
Last update
Mar 29, 2018

Study contacts

Jean STAGNARA, Dr
Contact
jeanstagnara@wanadoo.fr
0472830345 ext. +33

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Mar 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion